Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.
Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, Santos CS, Croda J, Homma A, Dellagostin OA, Haake DA, Reis MG, Ko AI. Silva EF, et al. Among authors: homma a. Vaccine. 2007 Aug 14;25(33):6277-86. doi: 10.1016/j.vaccine.2007.05.053. Epub 2007 Jun 14. Vaccine. 2007. PMID: 17629368 Free PMC article.
Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?
Martins MA, Silva ML, Marciano AP, Peruhype-Magalhães V, Eloi-Santos SM, Ribeiro jG, Correa-Oliveira R, Homma A, Kroon EG, Teixeira-Carvalho A, Martins-Filho OA. Martins MA, et al. Among authors: homma a. Clin Exp Immunol. 2007 Apr;148(1):90-100. doi: 10.1111/j.1365-2249.2006.03317.x. Clin Exp Immunol. 2007. PMID: 17309541 Free PMC article.
Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.
Martins MA, Silva ML, Elói-Santos SM, Ribeiro JG, Peruhype-Magalhães V, Marciano AP, Homma A, Kroon EG, Teixeira-Carvalho A, Martins-Filho OA. Martins MA, et al. Among authors: homma a. Vaccine. 2008 Feb 26;26(9):1173-84. doi: 10.1016/j.vaccine.2007.12.035. Epub 2008 Jan 14. Vaccine. 2008. PMID: 18243433
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.
Silva ML, Martins MA, Espírito-Santo LR, Campi-Azevedo AC, Silveira-Lemos D, Ribeiro JG, Homma A, Kroon EG, Teixeira-Carvalho A, Elói-Santos SM, Martins-Filho OA. Silva ML, et al. Among authors: homma a. Vaccine. 2011 Jan 10;29(3):583-92. doi: 10.1016/j.vaccine.2010.08.046. Epub 2010 Aug 21. Vaccine. 2011. PMID: 20732465
Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.
de Menezes Martins R, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, da Matta de Castro T, Homma A; Collaborative Group for Studies on Duration of Immunity from Yellow Fever Vaccine. de Menezes Martins R, et al. Among authors: homma a. Vaccine. 2018 Jun 27;36(28):4112-4117. doi: 10.1016/j.vaccine.2018.05.041. Epub 2018 May 18. Vaccine. 2018. PMID: 29784469 Free PMC article.
501 results